BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12835571)

  • 21. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
    Wirtz M; Helbig D
    Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
    Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retinoid oral photochemotherapy (RePUVA) as a combination treatment of mycosis fungoides].
    Hunziker T; Zala L; Krebs A
    Dermatologica; 1983; 166(3):165-8. PubMed ID: 6852330
    [No Abstract]   [Full Text] [Related]  

  • 25. Photochemotherapy for mycosis fungoides: current status.
    Watson A
    Australas J Dermatol; 1997 Feb; 38(1):9-11. PubMed ID: 9046645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of localized mycosis fungoides with digital UV photochemotherapy.
    Reidel U; Bechstein S; Lange-Asschenfeldt B; Beyer M; Vandersee S
    Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):333-40. PubMed ID: 26284356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon-alpha and PUVA therapy for mycosis fungoides].
    Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
    Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mycosis fungoides].
    Hoyez A; Lardinois J; Darras T; Bernard A; Ligny G
    Rev Med Brux; 1984 Dec; 5(10):671-5. PubMed ID: 6528142
    [No Abstract]   [Full Text] [Related]  

  • 30. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypopigmented mycosis fungoides in childhood and adolescence.
    Neuhaus IM; Ramos-Caro FA; Hassanein AM
    Pediatr Dermatol; 2000; 17(5):403-6. PubMed ID: 11085673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Imiquimod in treatment of palpebral mycosis fungoides].
    Soler-Machín J; Gilaberte-Calzada Y; Vera-Alvarez J; Coscojuela-Santaliestra C; Martínez-Morales J; Osán-Tello M
    Arch Soc Esp Oftalmol; 2006 Apr; 81(4):221-3. PubMed ID: 16688647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
    Swetter SM; Chen FW; Kim DD; Egbert BM
    J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of mycosis fungoides with imiquimod 5% cream.
    Ariffin N; Khorshid M
    Clin Exp Dermatol; 2006 Nov; 31(6):822-3. PubMed ID: 17040269
    [No Abstract]   [Full Text] [Related]  

  • 36. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma.
    Bong AB; Bonnekoh B; Franke I; Schön M; Ulrich J; Gollnick H
    Dermatology; 2002; 205(2):135-8. PubMed ID: 12218228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical carmustine (BCNU) in the treatment of mycosis fungoides.
    Zackheim HS
    Dermatol Ther; 2003; 16(4):299-302. PubMed ID: 14686972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.
    Suchin KR; Junkins-Hopkins JM; Rook AH
    Arch Dermatol; 2002 Sep; 138(9):1137-9. PubMed ID: 12224972
    [No Abstract]   [Full Text] [Related]  

  • 39. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.